These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 10900763

  • 1. [Clinical usefulness of free PSA/total PSA ratio in the early diagnosis of prostatic cancer].
    Laguna Pes MP, Guinda Sevillano C, Zazo Romojaro A, Domínguez J, García Luzón A, Borrego Hernando J, Gimeno Collado A.
    Arch Esp Urol; 2000 May; 53(4):333-41. PubMed ID: 10900763
    [Abstract] [Full Text] [Related]

  • 2. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F, Kwiatkowski MK, Piironen T, Pettersson K, Lümmen G, Wernli M, Wiefelspütz J, Graber SF, Goepel M, Huber A, Tscholl R.
    Cancer; 1998 Dec 15; 83(12):2540-7. PubMed ID: 9874461
    [Abstract] [Full Text] [Related]

  • 3. Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience.
    Recker F, Kwiatkowski MK, Huber A, Stamm B, Lehmann K, Tscholl R.
    J Urol; 2001 Sep 15; 166(3):851-5. PubMed ID: 11490232
    [Abstract] [Full Text] [Related]

  • 4. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system.
    Vashi AR, Wojno KJ, Henricks W, England BA, Vessella RL, Lange PH, Wright GL, Schellhammer PF, Weigand RA, Olson RM, Dowell BL, Borden KK, Oesterling JE.
    Urology; 1997 Jan 15; 49(1):19-27. PubMed ID: 9000179
    [Abstract] [Full Text] [Related]

  • 5. Percent free prostate specific antigen in the total prostate specific antigen 2 to 4 ng./ml. range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng./ml. range.
    Haese A, Dworschack RT, Partin AW.
    J Urol; 2002 Aug 15; 168(2):504-8. PubMed ID: 12131298
    [Abstract] [Full Text] [Related]

  • 6. Hormonal predictors of prostate cancer.
    Sofikerim M, Eskicorapci S, Oruç O, Ozen H.
    Urol Int; 2007 Aug 15; 79(1):13-8. PubMed ID: 17627161
    [Abstract] [Full Text] [Related]

  • 7. Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection.
    Irani J, Salomon L, Soulié M, Zlotta A, de la Taille A, Doré B, Millet C.
    Urology; 2005 Mar 15; 65(3):533-7. PubMed ID: 15780371
    [Abstract] [Full Text] [Related]

  • 8. The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan.
    Egawa S, Soh S, Ohori M, Uchida T, Gohji K, Fujii A, Kuwao S, Koshiba K.
    Cancer; 1997 Jan 01; 79(1):90-8. PubMed ID: 8988731
    [Abstract] [Full Text] [Related]

  • 9. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E.
    Hinyokika Kiyo; 1996 Oct 01; 42(10):795-804. PubMed ID: 8951478
    [Abstract] [Full Text] [Related]

  • 10. [The incidence of the variability of the free PSA/total PSA ratio on the early diagnosis of prostate cancer].
    de La Taille A, Houlgatte A, Houdelette P, Berlizot P, Fournier R, Ricordel I.
    Prog Urol; 1997 Jun 01; 7(3):455-63. PubMed ID: 9273075
    [Abstract] [Full Text] [Related]

  • 11. Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia.
    Paus E, Nilsson O, Børmer OP, Fosså SD, Otnes B, Skovlund E.
    J Urol; 1998 May 01; 159(5):1599-605. PubMed ID: 9554362
    [Abstract] [Full Text] [Related]

  • 12. The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population.
    Bangma CH, Rietbergen JB, Kranse R, Blijenberg BG, Petterson K, Schröder FH.
    J Urol; 1997 Jun 01; 157(6):2191-6. PubMed ID: 9146612
    [Abstract] [Full Text] [Related]

  • 13. [Serum and urine prostate-specific antigen ratio: its value in the distinction between prostate cancer and adenoma when serum prostate-specific antigen level is between 4 and 10 ng/ml].
    Irani J, Millet C, Levillain P, Doré B, Bégon F, Aubert J.
    Chirurgie; 1997 Jun 01; 122(8-9):478-82. PubMed ID: 9616891
    [Abstract] [Full Text] [Related]

  • 14. Measurement of prostate specific antigen complexed to alpha1-antichymotrypsin to avoid unnecessary biopsy in patients with serum prostate specific antigen levels 4-20 ng/mL.
    Nakano Y, Okamura K, Takamura S, Okamoto N, Narishima M, Yoshino Y, Hattori R, Ono Y, Ohshima S, Nagasaka T.
    Int J Urol; 2005 Aug 01; 12(8):721-7. PubMed ID: 16174045
    [Abstract] [Full Text] [Related]

  • 15. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer].
    Iwaki H, Kajita Y, Shimizu Y, Yamauchi T.
    Hinyokika Kiyo; 2001 Mar 01; 47(3):169-74. PubMed ID: 11329957
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.
    Serdar MA, Oguz O, Olgun A, Seçkin B, Ilgan S, Hasimi A, Salih M, Peker F, Kutluay T.
    Ann Clin Lab Sci; 2002 Mar 01; 32(1):22-30. PubMed ID: 11848613
    [Abstract] [Full Text] [Related]

  • 17. Ratio of free-to-total prostate specific antigen correlates with tumor volume in patients with increased prostate specific antigen.
    Grossklaus DJ, Shappell SB, Gautam S, Smith JA, Cookson MS.
    J Urol; 2001 Feb 01; 165(2):455-8. PubMed ID: 11176395
    [Abstract] [Full Text] [Related]

  • 18. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
    Aksoy Y, Oral A, Aksoy H, Demirel A, Akcay F.
    Ann Clin Lab Sci; 2003 Feb 01; 33(3):320-3. PubMed ID: 12956448
    [Abstract] [Full Text] [Related]

  • 19. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.
    Ramos CG, Carvahal GF, Mager DE, Haberer B, Catalona WJ.
    J Urol; 1999 Nov 01; 162(5):1587-90. PubMed ID: 10524873
    [Abstract] [Full Text] [Related]

  • 20. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME.
    Clin Lab Sci; 2001 Nov 01; 14(2):102-7. PubMed ID: 15625982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.